Gynecologic Radiation Therapy

Section 1:Radiologic Imaging of Gynecologic MalignanciesGeneral Considerations.-Section 2: Clinical Utility of Imaging for EBRTIssues with Imaging in the Use of Radiation for Locally Advanced Cervical Cancer.-The Use of Image Guidance in External Beam Planning.-The Use of Imaging for 3D Conformal and for IMRT in Vaginal/Vulvar cancer.-Section 3: Image Guided Brachytherapy, Medical and Biological Treatment PlanningAdaptive Contouring of GTV, CTV and Organs and Ris.-Medical Aspects of Treatment Planning.-Radiobiologic Aspects of Brachytherapy in the Era of 3D Imaging.-Section 4: Image Guided Brachytherapy: Physics Treatment Planning3D Image Guided Treatment Planning.-Section 5: Practical ApproachesApplicator Selection, Insertion adn Imaging of 3D Image-Based Intracavitary Brachytherapy.-Post-operative Vaginal Cylinder Brachytherapy.- Template-Guided Interstittial BrachytherapySection 6: Outcomes.-Clinical Outcomes of 3D External Beam and Brachytherapy.

Akila Viswanathan, M.D., M.P.H. has served as the Chief of Gynecologic Radiation Oncology and Director of the 3D Image-Guided Gynecologic Brachytherapy Program at the Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, since 2002. Dr. Viswanathan completed her undergraduate studies at Harvard University in Cambridge, Massachusetts, and received her medical degree from the University of Pittsburgh School of Medicine. She completed her residency at the Harvard Joint Center for Radiation Therapy and earned both Master's in Public Health and Master's of Science in Epidemiology degrees at the Harvard School of Public Health. At the Dana-Farber/Brigham and Women's, she led the development and growth of the gynecology practice and designed clinical trials of real-time MRI-based image-guided brachytherapy and CT-based imaging for gynecologic cancer patients. She implemented the first use of IMRT techniques at the Dana-Farber/Brigham and Women's for selected gynecologic cancer patients. In addition to clinical outcomes, Dr. Viswanathan's research focuses on risk factors and prevention of endometrial cancer, using the Nurses' Health Study. In 2005 she was awarded a National Institutes of Health K-award to further these research pursuits. She is actively involved in protocol development, serving as principal investigator for an accruing trial, and works with the Radiation Therapy Oncology Group Gynecology Steering Committee to study novel therapeutics in gynecologic cancers. Dr. Viswanathan has lectured widely on gynecologic malignancies and their treatment. Her lectures have brought image-guided brachytherapy and its status in the U.S. to the forefront at local, regional, national and international conferences. She has also led panels, courses and schools for the American Brachytherapy Society and the American Society for Therapeutic Radiology and Oncology, and has served on the board of directors of the American BrachytherapySociety for 3 years. She serves